A case report on the use of topical cysteamine 5% cream in the management of refractory postinflammatory hyperpigmentation (PIH) resistant to triple combination cream (hydroquinone, topical corticosteroids, and retinoids)

@article{Mathe2020ACR,
  title={A case report on the use of topical cysteamine 5\% cream in the management of refractory postinflammatory hyperpigmentation (PIH) resistant to triple combination cream (hydroquinone, topical corticosteroids, and retinoids)},
  author={N Mathe and M. Balogun and J. Yoo},
  journal={Journal of Cosmetic Dermatology},
  year={2020},
  volume={20},
  pages={204 - 206}
}
Postinflammatory hyperpigmentation (PIH) occurs as a result of different inflammatory dermatoses and exogenous factors in individuals with darker skin types. With current skin lightening treatments, there are concerns about irritation leading to worsening of their underlying inflammatory skin condition or worsening of PIH. 
Efficacy of topical cysteamine hydrochloride in treating melasma: a systematic review
TLDR
A topical 5% cysteamine hydrochloride formulation, the structure of which is notably more stable and with a less foul odor than its prior counterparts, is assessed in the treatment of melasma.
Multiple drugs
  • Medicine
    Reactions Weekly
  • 2021
TLDR
A 20-year-old woman presented with facial hyperpigmentation and experienced worsening of PIH following discontinuation of hydrocortisone/hydroquinone/tretinoin for its treatment, so she started applying mercaptamine [cysteamine] alongside strict photoprotection, resulting in significant improvement, without side effects.
Implications of Oxidative Stress in the Pathogenesis and Treatment of Hyperpigmentation Disorders
TLDR
This work reviews oxidative and antioxidant systems, oxidative stress-induced signal transduction mechanisms, and effects of antioxidant drugs used in preclinical and clinical settings in hyperpigmentation disorders.

References

SHOWING 1-9 OF 9 REFERENCES
UK‐based dermatologist online survey on the current practice and training in the management of melasma and postinflammatory hyperpigmentation
TLDR
The current gold standard treatment is triple combination cream containing hydroquinone, retinoid and topical steroids but concerns over its long-term use including exogenous ochronosis, along with the lack of guidelines on the management of hyperpigmentary disorders, have contributed to the inconsistent practice amongst dermatologists.
Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double‐blind placebo‐controlled trial
Melasma is a difficult‐to‐treat hyperpigmentary disorder. While cysteamine is a known potent depigmenting agent, its efficacy in treating melasma has not been tested.
Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study
TLDR
Cysteamine cream showed significant efficacy in decreasing melanin content of the lesions, as established by Dermacatch® as a new measuring method.
Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal
Postinflammatory hyperpigmentation (PIH) commonly occurs, but the histopathological features are not well characterized.
Peroxidase-Mediated Mechanisms Are Involved in the Melanocytotoxic and Melanogenesis-Inhibiting Effects of Chemical Agents
TLDR
It is proposed that peroxidase-mediated mechanisms, in addition to or in several instances rather than tyrosinase- mediated mechanisms, can explain the melanocytotoxic and depigmenting properties of such agents.
Evaluation of the efficacy of cysteamine cream compared to hydroquinone cream in the treatment of melasma: a randomised, double-blind, multicentre trial
  • [Internet]
  • 2019
Evaluation of efficacy of cysteamine 5% cream in treatment of epidermal melasma: a randomised double-blinded placebo controlled trial
  • Br J Dermatol
  • 2015